Also known as: Aclidinium bromide
Aclidinium is indicated for:
Population group: both men and women, only adults (18 - 65 years old)
Aclidinium is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
For this indication, competent medicine agencies globally authorize below treatments (click for details):